Fig. 1: This map illustrates the distribution of cardiomyopathy research across African countries, highlighting regions with clinical studies, genetic testing, or both.

Green areas represent countries where only clinical studies on cardiomyopathies have been conducted, indicating efforts to understand disease prevalence, types, and associated risk factors within the local population. Purple areas denote countries where genetic testing has been performed, reflecting an interest in identifying genetic variants and understanding hereditary aspects of cardiomyopathies. Green with stripes marks countries where both clinical studies and genetic testing have been undertaken, showcasing a more comprehensive approach that integrates epidemiological data with genetic insights. This map underscores the regional variability in research focus and resources, emphasizing areas where further genetic testing may enhance the understanding and management of cardiomyopathies in Africa.